<- Go home

Added to YB: 2020-02-09

Pitch date: 2020-02-09

BSTC [bullish]

BioSpecifics Technologies Corp.

+39.7%

current return

Author Info

No bio for this author

Company Info

BioSpecifics Technologies Corp., a biopharmaceutical company, develops an injectable collagenase clostridium histolyticum for various indications in the United States and internationally.

Market Cap

$650.2M

Pitch Price

$63.37

Price Target

N/A

Dividend

N/A

EV/EBITDA

N/A

P/E

37.52

EV/Sales

N/A

Sector

Biotechnology

Category

N/A

Show full summary:
BIOSPECIFICS TECHNOLOGIES CP BSTC

A summary for this pitch has not been created yet.

Read full article (0 min)